Injected Amikacin Sulfate USP 500 mg
Presentation: Box with 10 ampoules 500 mg/2ml
AMIKACIN ULTIMATE is indicated in short term treatment of serious infections caused by susceptible strains of aerobic Gram-negative bacteria and some types of staphylococcus, with activity reported against Nocardia asteroids, Mycobacterium tuberculosis, and some atypical strains of mycobacteria.
Clinical trials have demonstrated that amikacin sulfate is effective in bacterial septicemia (including neonatal sepsis, serious infections of the respiratory tract, bones and articulations, central nervous system, including meningitis, and soft tissue and skin infections); intraabdominal infections, including peritonitis; and in burns and postoperative infections.
As prescribed by physician